Amphastar Pharmaceuticals (AMPH) Work In Process (2015 - 2026)

Amphastar Pharmaceuticals' Work In Process history runs 12 years deep, the most recent figure standing at $42.6 million for Q1 2026.

• In Q1 2026, Work In Process fell 2.6% year-over-year to $42.6 million; the TTM figure through Mar 2026 stood at $42.6 million (down 2.6% YoY), while the FY2025 annual figure was $40.4 million, up 23.27% from the prior year.
• Work In Process was $42.6 million for Q1 2026 at Amphastar Pharmaceuticals, up from $40.4 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $43.8 million in Q1 2025 to a low of $28.3 million in Q3 2023.
• Historically, Work In Process has averaged $37.1 million across 5 years, with a median of $38.6 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Work In Process dropped 26.63% in 2023, then jumped 31.34% in 2025.
• A 5-year view of Work In Process shows it stood at $37.1 million in 2022, then declined by 16.9% to $30.8 million in 2023, then climbed by 6.44% to $32.8 million in 2024, then rose by 23.27% to $40.4 million in 2025, then climbed by 5.44% to $42.6 million in 2026.
• The last three Work In Process figures came in at $42.6 million (Q1 2026), $40.4 million (Q4 2025), and $42.5 million (Q3 2025), per Business Quant data.